234 related articles for article (PubMed ID: 16791660)
1. Optimal therapy for severe pneumococcal community-acquired pneumonia.
Luján M; Gallego M; Rello J
Intensive Care Med; 2006 Jul; 32(7):971-80. PubMed ID: 16791660
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
3. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
[TBL] [Abstract][Full Text] [Related]
4. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
[TBL] [Abstract][Full Text] [Related]
6. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
Yayan J
Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
9. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
Mufson MA; Chan G; Stanek RJ
Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance and treatment of community-acquired pneumonia.
Mandell LA
Clin Chest Med; 2005 Mar; 26(1):57-64. PubMed ID: 15802166
[TBL] [Abstract][Full Text] [Related]
12. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
Viasus D; Simonetti AF; Garcia-Vidal C; Niubó J; Dorca J; Carratalà J
J Antimicrob Chemother; 2017 Feb; 72(2):547-553. PubMed ID: 27798219
[TBL] [Abstract][Full Text] [Related]
13. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
[TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU.
Moine P; Vercken JB; Chevret S; Gajdos P
Scand J Infect Dis; 1995; 27(3):201-6. PubMed ID: 8539541
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic strategy in severe community-acquired pneumococcal pneumonia.
Le Bris-Tomczak A; Bedos JP; Billon C; Samdjee F; Le Monnier A
Med Mal Infect; 2012 May; 42(5):226-34. PubMed ID: 22583782
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the treatment of pneumococcal community-acquired pneumonia.
Feldman C; Anderson R
Future Microbiol; 2006 Oct; 1(3):271-81. PubMed ID: 17661640
[TBL] [Abstract][Full Text] [Related]
20. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
